Effectiveness and safety of dupilumab for the treatment of severe asthma in a real‐life French multi‐centre adult cohort

The Burden of Severe Asthma in France: A Case-Control Study Using a Medical Claims Database

(2019) Arnaud Bourdin et al.   Journal of Allergy and Clinical Immunology-In Practice

Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma

(2018) Klaus F. Rabe et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

(2018) Mario Castro et al.   NEW ENGLAND JOURNAL OF MEDICINE

Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: Results of a single-centre observational study

(2018) Corrado Pelaia et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Randomised controlled trials in severe asthma: selection by phenotype or stereotype

(2018) Thomas Brown et al.   EUROPEAN RESPIRATORY JOURNAL

Clinical and economic burden of severe asthma: A French cohort study

(2018) Clementine Nordon et al.   RESPIRATORY MEDICINE

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

(2017) Andrew Blauvelt et al.   LANCET

‘Real-life’ effectiveness studies of omalizumab in adult patients with severe allergic asthma: systematic review

(2016) I. Abraham et al.   ALLERGY

Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial

(2016) Sally Wenzel et al.   LANCET

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

(2016) Eric L. Simpson et al.   NEW ENGLAND JOURNAL OF MEDICINE

External Validity of Randomized Controlled Trials in Severe Asthma

(2015) Laurie Pahus et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The prevalence of severe refractory asthma

(2015) Pieter-Paul W. Hekking et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Targeting key proximal drivers of type 2 inflammation in disease

(2015) Namita A. Gandhi et al.   NATURE REVIEWS DRUG DISCOVERY

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

(2013) K. F. Chung et al.   EUROPEAN RESPIRATORY JOURNAL

Dupilumab in Persistent Asthma with Elevated Eosinophil Levels

(2013) Sally Wenzel et al.   NEW ENGLAND JOURNAL OF MEDICINE

“Real-life” effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study

(2009) G. Brusselle et al.   RESPIRATORY MEDICINE